Related Experiment Video
Updated: Jul 1, 2026

Protocol for the Differentiation of Human Induced Pluripotent Stem Cells into Mixed Cultures of Neurons and Glia for Neurotoxicity Testing
Published on: June 9, 2017
The hepatotoxic metabolite of acetaminophen directly activates the Keap1-Nrf2 cell defense system
Ian M Copple1, Christopher E Goldring, Rosalind E Jenkins
1Department of Pharmacology and Therapeutics, School of Biomedical Sciences, The University of Liverpool, Liverpool, UK.
Unlabelled:
The transcription factor Nrf2 regulates the expression of numerous cytoprotective genes in mammalian cells. We have demonstrated previously that acetaminophen activates Nrf2 in mouse liver following administration of non-hepatotoxic and hepatotoxic doses in vivo, implying that Nrf2 may have an important role in the protection against drug-induced liver injury. Nrf2 activation has been proposed to occur through the modification of cysteine residues within Keap1, the cytosolic repressor of Nrf2. We hypothesized that acetaminophen activates Nrf2 via the formation of its reactive metabolite N-acetyl-p-benzoquinoneimine (NAPQI), which may disrupt the repression of Nrf2 through the modification of cysteine residues within Keap1. Here, we show that NAPQI can directly activate the Nrf2 pathway in mouse liver cells, inducing an adaptive defense response that is antagonized by RNA interference targeted against Nrf2. Furthermore, mass spectrometric analysis shows that NAPQI selectively modifies cysteine residues in Keap1, both in recombinant protein in vitro and in cells ectopically expressing Keap1. Using this cell-based model, we demonstrate that activation of Nrf2 by NAPQI and a panel of probe molecules [dexamethasone 21-mesylate, 15-deoxy-Delta-((12,14))-prostaglandin J(2), 2,4-dinitrochlorobenzene, and iodoacetamide] correlates with the selective modification of cysteine residues located within the intervening region of Keap1. However, substantial depletion of glutathione (to less than 15% of basal levels) by buthionine sulfoximine, which does not directly modify Keap1, is also sufficient to activate Nrf2.
Conclusion:
Nrf2 can be activated via the direct modification of cysteine residues located within the intervening region of Keap1, but also via the substantial depletion of glutathione without the requirement for direct modification of Keap1. It is possible that both of these mechanisms contribute to the activation of Nrf2 by acetaminophen.
Insights
Acetaminophen metabolite NAPQI directly activates the Nrf2 pathway by modifying Keap1. Nrf2 activation also occurs via glutathione depletion, suggesting dual mechanisms protect against drug-induced liver injury.
Area of Science:
- Biochemistry
- Molecular Biology
- Toxicology
Background:
- Nuclear factor erythroid 2-related factor 2 (Nrf2) controls cytoprotective genes.
- Acetaminophen activates Nrf2, suggesting a role in preventing drug-induced liver injury.
- Nrf2 activation is linked to cysteine modification in Keap1, its repressor.
Purpose of the Study:
- To investigate if acetaminophen's metabolite, NAPQI, activates Nrf2 by modifying Keap1.
- To elucidate the mechanisms of Nrf2 activation by acetaminophen.
Main Methods:
- NAPQI administration to mouse liver cells.
- RNA interference targeting Nrf2.
- Mass spectrometry to analyze Keap1 cysteine modification.
- Cell-based models with probe molecules and glutathione depletion.
Main Results:
- NAPQI directly activated the Nrf2 pathway in mouse liver cells.
- NAPQI selectively modified cysteine residues in Keap1.
- Glutathione depletion also activated Nrf2, independent of direct Keap1 modification.
Conclusions:
- Nrf2 activation can occur through direct Keap1 cysteine modification by NAPQI.
- Nrf2 can also be activated by significant glutathione depletion.
- Both pathways may contribute to acetaminophen-induced Nrf2 activation.
Related Concept Videos
Bioactivation and Tissue Toxicity
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Phase II Reactions: Acetylation Reactions
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
